Centene (CNC) just delivered one of those conference presentations that makes you wonder why companies even show up. The managed care giant’s CEO Sarah London took the stage at the Barclays Global Healthcare Conference on Tuesday and essentially told investors that Obamacare enrollment is falling off a cliff — faster than anyone expected.
The numbers are brutal. Centene’s ACA marketplace membership is projected to drop to 3.5 million by the end of Q1, down from 5.5 million in December. That’s 2 million members gone in roughly 90 days. The stock responded accordingly, plunging 14% in a single session to claim the title of worst performer in the entire S&P 500 on Tuesday.
London had warned that the overall ACA marketplace would contract “somewhere between the high teens and the mid-thirties” percentage-wise. She then casually mentioned Centene would likely finish “at the higher end of that and possibly higher than the top end.” Translation: it’s worse than our worst-case scenario.
Part of this is deliberate. Centene made strategic pricing moves at the start of 2026 designed to prioritize profitability over member count. But “we chose to lose members” is a tough sell when you’re simultaneously telling Wall Street that your Medicare Advantage division is still unprofitable and won’t break even until 2027.
The broader ACA picture adds another layer of uncertainty. Americans are dropping coverage as costs soar, and the Trump administration’s proposed flat Medicare reimbursement rates for 2027 — with a final decision due by April 6 — could squeeze the entire managed care sector further.
Analyst reactions were predictably split. Mizuho slashed its price target to $41 from $47, staying Neutral. Truist kept its Buy rating at $49, apparently choosing optimism. Cantor Fitzgerald went with Neutral and a $41 target, describing 2026 as “challenging” — which in analyst-speak means “buckle up.”
Centene is now down nearly 10% year-to-date against a modest 0.7% decline for the S&P 500. For value hunters, the company still guided to $3+ adjusted EPS. But with membership in freefall and Medicare Advantage bleeding money, that guidance feels like it’s held together with duct tape and good intentions.